2016
DOI: 10.3389/conf.fbioe.2016.01.02327
|View full text |Cite
|
Sign up to set email alerts
|

Using BioBots for standardizing the 3D bioprinting of liver bioink

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…BioBots, USA developed a human liver tissue using their commercially available bioink called BioGel and HepG2 cells. The BioBots demonstrated the fabrication of high-resolution liver tissue construct and it remained viable for 2 weeks [ 282 ]. Sarah et al demonstrated the automated fabrication of a vascularized human liver tissue construct using primary human hepatocytes and non-parenchymal cells along with isolated fragments of intact human micro vessels as vascular precursors [ 283 ].…”
Section: Applications Of 3d Bioprinting For Liver Diseasesmentioning
confidence: 99%
“…BioBots, USA developed a human liver tissue using their commercially available bioink called BioGel and HepG2 cells. The BioBots demonstrated the fabrication of high-resolution liver tissue construct and it remained viable for 2 weeks [ 282 ]. Sarah et al demonstrated the automated fabrication of a vascularized human liver tissue construct using primary human hepatocytes and non-parenchymal cells along with isolated fragments of intact human micro vessels as vascular precursors [ 283 ].…”
Section: Applications Of 3d Bioprinting For Liver Diseasesmentioning
confidence: 99%